Merck to develop vaccine manufacturing processes with International Vaccine Institute
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
Click on this link for more information.
